DOUGLAS J HARRISON to Osteosarcoma
This is a "connection" page, showing publications DOUGLAS J HARRISON has written about Osteosarcoma.
Connection Strength
1.414
-
Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. Pediatr Blood Cancer. 2023 Jan; 70(1):e30017.
Score: 0.519
-
The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma. Adv Exp Med Biol. 2020; 1257:75-83.
Score: 0.428
-
Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. Curr Treat Options Oncol. 2017 04; 18(4):24.
Score: 0.354
-
Advances in the Management of Pediatric Sarcomas. Curr Oncol Rep. 2020 11 16; 23(1):3.
Score: 0.114